Bioventus Inc.
BVS
$8.50
-$0.01-0.12%
NASDAQ
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 35.85M | 51.24M | 42.16M | 32.91M | 22.80M |
| Total Receivables | 120.53M | 128.30M | 130.40M | 132.37M | 118.08M |
| Inventory | 83.19M | 82.24M | 96.27M | 96.47M | 94.05M |
| Prepaid Expenses | 10.26M | 11.07M | 12.06M | 13.46M | 14.44M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 249.81M | 272.84M | 280.90M | 275.20M | 249.37M |
|
|
|||||
| Total Current Assets | 249.81M | 272.84M | 280.90M | 275.20M | 249.37M |
| Net Property, Plant & Equipment | 25.98M | 27.02M | 28.81M | 30.74M | 32.35M |
| Long-term Investments | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M |
| Goodwill | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M |
| Total Other Intangibles | 359.66M | 368.42M | 377.40M | 386.95M | 395.73M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.52M | 5.52M | 4.75M | 4.75M | 4.75M |
| Total Assets | 650.54M | 683.56M | 701.59M | 706.79M | 691.41M |
|
|
|||||
| Total Accounts Payable | 24.05M | 10.93M | 26.65M | 24.25M | 19.20M |
| Total Accrued Expenses | 37.42M | 51.62M | 43.47M | 42.10M | 35.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 22.91M | 19.21M | 15.66M | 47.77M | 41.70M |
| Total Finance Division Other Current Liabilities | 63.72M | 78.62M | 75.98M | 71.57M | 77.91M |
| Total Other Current Liabilities | 63.72M | 78.62M | 75.98M | 71.57M | 77.91M |
| Total Current Liabilities | 148.10M | 160.38M | 161.75M | 185.68M | 174.75M |
|
|
|||||
| Total Current Liabilities | 148.10M | 160.38M | 161.75M | 185.68M | 174.75M |
| Long-Term Debt | 253.33M | 278.95M | 311.33M | 297.88M | 308.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 12.18M | 13.19M | 14.18M | 15.01M | 15.84M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.67M | 2.60M | 7.08M | 6.92M | 6.76M |
| Total Liabilities | 416.27M | 455.11M | 494.34M | 505.49M | 505.94M |
|
|
|||||
| Common Stock & APIC | 523.00M | 520.93M | 517.62M | 514.86M | 510.50M |
| Retained Earnings | -331.82M | -334.93M | -349.68M | -352.84M | -360.30M |
| Treasury Stock & Other | -2.28M | -1.90M | -1.84M | -774.00K | -2.06M |
| Total Common Equity | 188.90M | 184.11M | 166.10M | 161.24M | 148.14M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 188.90M | 184.11M | 166.10M | 161.24M | 148.14M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 45.36M | 44.34M | 41.16M | 40.06M | 37.34M |
| Total Equity | 234.27M | 228.45M | 207.26M | 201.30M | 185.48M |
|
|
|||||